Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

Summary

This is an investigator initiated trial to assess the efficacy and safety of a GCC-targeting CAR-T therapy (REVO-UWD-01) in the metastatic colorectal cancer. It also aims to explore the feasibility of using a novel universal CAR-T cell platform.

Timeline

Start

2024-10-23

Primary completion

2027-10-20

Completion

2027-12-30

Outcome

Outcome not reported

Stopped: “Because the implementation of the new regulation policy by the Chinese authority”

Drugs

Indications